INNOVATIVE DIAGNOSTICS

INNOVATIVE DIAGNOSTICS specializes in the design, manufacture, and delivery of proprietary diagnostic test kits for veterinary and animal health applications, with a primary focus on enzyme-linked immunosorbent assay (ELISA) technology. The company’s core technical expertise lies in developing double-antigen ELISA platforms for the detection of infectious agents such as glanders, a high-consequence zoonotic disease. Their capability includes assay optimization, reagent formulation, quality control validation, and scalable production of clinical-grade diagnostic kits compliant with federal biosecurity standards. A key differentiator is their targeted innovation in antigen-antibody binding kinetics, enabling high specificity and sensitivity in field-deployable formats suitable for USDA laboratories and field veterinarians. The contractor maintains a consistent relationship with the U.S. Department of Agriculture, particularly its Agricultural Research Service divisions, delivering diagnostic solutions that support national animal disease surveillance and eradication programs. Work is centered on rapid-response procurement of validated test kits to support outbreak mitigation, biocontainment protocols, and livestock health monitoring across U.S. agricultural systems. The primary NAICS classification of 334516—Analytical Laboratory Instrument Manufacturing—reflects their role as a precision diagnostics manufacturer, not merely a distributor. This positions them within the niche market for specialized in-vitro diagnostic devices used in government animal health labs, distinguishing them from general biomedical suppliers. Their focus on veterinary immunodiagnostics aligns with USDA’s mission to safeguard U.S. agricultural biosecurity. INNOVATIVE DIAGNOSTICS operates as a small business entity under structure code ZZ, with no disclosed federal certifications. Located in Grabels, N/A, the company maintains a focused government market presence, serving exclusively federal agencies engaged in animal health and agricultural biodefense. Their operational footprint is defined by technical precision rather than geographic scale, emphasizing reliability and regulatory compliance in mission-critical diagnostics.